N9 World Technologies, a subsidiary of Bengaluru Resil Chemicals, and Consolidated Pathways Inc., USA have inked a deal to introduce the Swiss antiviral and antimicrobial technologies into sustainable, cost effective custom blends for India’s textile industry.
The technology promises to destroy viruses in textiles including coronavirus.
Currently many of the manufacturers in India are using N9’s products for the production of antibacterial masks. This collaboration will help both the companies to expand the offerings of product benefits to the global textile industry.
At the centre of the agreement is N9’s durable antiviral technology VIROBAN that helps increase the fabric resilience against viruses including coronavirus.
The VIROBAN N9 XTS-18 develops a highly cationic charge density on the textile that deactivates the spread of viruses and bacteria when in contact.
The technology is ISO 18184 testified and is proven to be 99.99 per cent effective against preventing the transmission of viruses. The VIROBAN polymers are highly compatible with other textiles while remaining gentle on human skin.
The development is the need of the hour that can help the world in the fight against the pandemic by restricting and controlling the virus transmission.
Vikram Rao, Managing Director, N9 World Technologies, said “With the onslaught of the pandemic, consumers are increasingly seeking protection and safety in almost everything they breathe, touch or wear. We are committed to keeping our customers safe and that is why we have partnered with Consolidated Pathways & SANITIZED AG.”
He added “With this partnership, N9 World Technologies is now a ‘One Stop Shop’ for Global Brands & Retailers who are seeking innovative and sustainable specialty finishes for their textile products. A worldwide business development team is already in place for marketing and servicing customers with these proven technologies with global regulatory approvals.”
Ganesh Srinivasan, CEO, Resil Chemicals, said “Current annual Indian mill made fabric production for domestic and an export market is nearly 7 billion square metres. This can possibly create the potential for use for antibacterial & antiviral products to the tune of Rs. 140 to 150 crore. With N9’s strong local service and technical support, we aim to capture a significant market share from this emerging opportunity. N9’s manufacturing capability within the country can help scale up the production of the antiviral products quickly and market them globally with this association.”
N9 World Technologies Pvt. Ltd., a wholly owned subsidiary of Bengaluru-based Resil Chemicals, is a manufacturer & marketer of specialty chemicals in Antibacterial, Cooling & Dynamic Drying technologies.
Pathway, based in USA is a brand and technical representative for sanitised products and supports the advancement of the trusted Sanitized® Quality Seal and related branding concepts to the global textile industry.
“We are excited to partner with N9 World Technologies. This partnership provides a unique combination of technologies, market information and expertise that can help brands and retailers enhance their products in ways that are meaningful to consumers,” said James Krueger, CEO of Consolidated Pathways.
Resil Chemicals enjoys the trust of over 150 brands and retailers across the world for its products like COOLITTM, NeudriTM, N9 Pure SilverTM, etc.